Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Speed Care Mineral GmbH holds a patent portfolio in the Biotechnology & Pharmaceuticals technology area. There is currently 1 pending office action for the company. This suggests a targeted approach to securing intellectual property, with a single application currently undergoing substantive review. The current prosecution activity reflects a focused effort to protect a specific mineral-based or pharmaceutical innovation.
The prosecution is managed by a distinct examiner within 1 distinct art unit. This indicates that the company's current biological or pharmaceutical technology is being assessed by a specialized unit. KAILA ANGELIQUE CRAIG is the busiest examiner, currently responsible for the busiest examiner pending office action. This examiner is the sole point of contact for the company's active matters, which centralizes the legal strategy and communication with the patent office.
The involvement of 1 distinct art unit means that the technical arguments can be highly specialized for that group's standards. Since there is the pending office action, the company can dedicate its full attention to the issues raised by KAILA ANGELIQUE CRAIG. This focused environment simplifies the prosecution process within the Biotechnology & Pharmaceuticals field, allowing for a more efficient resolution of any outstanding rejections.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| CRAIG, KAILA ANGELIQUE | 1 | 33.8% | +25.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17434217 | PASTE FOR MARKING TEXTILE FABRICS AND/OR OTHER PRODUCTS INCAPABLE OF X-RAY CONTRAST | CRAIG, KAILA ANGELIQUE | 3d overdue |
| Art Unit | Apps |
|---|---|
| 1618 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17434217 | PASTE FOR MARKING TEXTILE FABRICS AND/OR OTHER PRODUCTS INCAPABLE OF X-RAY CONTRAST | CRAIG, KAILA ANGELIQUE | 1618 | §103 | Non-Final OA | 3d overdue | Pending | Aug 26, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialSpeed Care Mineral GmbH has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Kaila Angelique Craig has the most, with 1 of Speed Care Mineral GmbH's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
